Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

Learn how early developmental patterns can influence your lifetime cancer risk and the type of cancer that may develop.

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Researchers have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice ...

Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic ...

“It is very rare for a compound to shrink tumors in mouse models of breast cancer, let alone completely eradicate those tumors with a single dose, so we are eager for ErSO-TFPy to advance for ...

However, a new drug candidate could hold the potential to eliminate the need for such a grueling process, after a study in mice found that it wiped out a range of breast tumors in a single dose.

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...